Of note, adverse risk genes such as ASXL1, EZH2 and TET2wt, were in many cases associated with high risk parameters, such as CMML-2, lower Hg levels, higher leukocyte counts, higher risk groups of CPSS and GFM models or progression to AML. This evidence concerns the gene EZH2 and acute myeloid leukemia.